The cancer-testis antigen a-kinase anchor protein 3 facilitates breast cancer progression via activation of the PTEN/PI3K/AKT/mTOR signaling. Issue 4 (1st April 2022)
- Record Type:
- Journal Article
- Title:
- The cancer-testis antigen a-kinase anchor protein 3 facilitates breast cancer progression via activation of the PTEN/PI3K/AKT/mTOR signaling. Issue 4 (1st April 2022)
- Main Title:
- The cancer-testis antigen a-kinase anchor protein 3 facilitates breast cancer progression via activation of the PTEN/PI3K/AKT/mTOR signaling
- Authors:
- Zhan, Chuan-Hua
Ding, Dong-Shen
Zhang, Wei
Wang, Hong-Liang
Mao, Zhe-Yu
Liu, Guo-Jun - Abstract:
- ABSTRACT: The cancer-testis antigen A-kinase anchor protein 3 (AKAP3) has been shown to have a strong association with breast cancer (BC). However, its role in BC progression received scant attention. We aimed to explore the prognostic implication of aberrant AKAP3 expression for a better knowledge of BC progression and improved treatment. AKAP3 expression was quantitated using tissue microarrays and immunohistochemistry (IHC). Cell viability, invasion, migration, apoptosis, and expressions of PTEN/PI3K/AKT/mTOR signaling components were assessed in AKAP3-overexpressed or si-AKAP3-transfected BC cells. Finally, elevated AKAP3 expression was observed in BC versus paracancerous tissues. BC patients with high AKAP3 expression showed a worse prognosis than low expression patients ( P < 0.0001). AKAP3 overexpressions fueled cell growth, proliferation, migration, and invasion in HCC1937 and MDA-MB-468 BC cell lines, alongside increased expressions of PI3K/AKT/mTOR signaling components and PTEN suppression. These effects were pronouncedly reversed, together with elevated apoptosis, in cells transfected with si-AKAP3. Therefore, AKAP3 is upregulated in BC and promotes BC cell growth, invasion, and migration via PTEN/PI3K/AKT/mTOR signaling activation. It may serve as a prognosis indicator for BC survival. GRAPHICAL ABSTRACT: uf0001
- Is Part Of:
- Bioengineered. Volume 13:Issue 4(2022)
- Journal:
- Bioengineered
- Issue:
- Volume 13:Issue 4(2022)
- Issue Display:
- Volume 13, Issue 4 (2022)
- Year:
- 2022
- Volume:
- 13
- Issue:
- 4
- Issue Sort Value:
- 2022-0013-0004-0000
- Page Start:
- 8478
- Page End:
- 8489
- Publication Date:
- 2022-04-01
- Subjects:
- Cancer-testis antigen -- A-kinase anchor protein 3 protein -- breast neoplasms -- prognosis -- mechanism
Biomedical engineering -- Periodicals
Biotechnology -- Periodicals
Microbiology -- Periodicals
660.6 - Journal URLs:
- http://www.tandfonline.com/toc/kbie20/current ↗
http://www.landesbioscience.com/journals/bioe/ ↗
http://www.tandfonline.com/ ↗ - DOI:
- 10.1080/21655979.2022.2051687 ↗
- Languages:
- English
- ISSNs:
- 2165-5987
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 21230.xml